血小板膜糖蛋白Ⅱb/Ⅲa拮抗剂临床应用的研究进展
被引量:1
摘要
血小板在动脉血栓形成中起着重要的作用.血小板在受到各种刺激后引起活化,产生血小板聚集,导致血栓形成,并常成为致命的因素之一.
出处
《血栓与止血学》
2002年第1期35-38,共4页
Chinese Journal of Thrombosis and Hemostasis
参考文献19
-
1[1]Gershlick AH. Antiplatelet therapy. Hospital Medicine, January,2000, 61: 15-23.
-
2[2]Steven R, Steinhubl MD. Antiplatelet agents in cardiology: The choice of therapy. Ann Thorac Surg, 2000, 70: 3-8.
-
3[3]Dorid A, Vorchheimer D, Badinon J, et al. Platelet glycoprotein Ⅱ b/Ⅲ a antagonists in cardiovascular disease. JAMA April, 1999, 281:1407-1414.
-
4[4]Cook JJ, Bednar B, Lymch JL, et al. Tirofiban(AggrastatR). Cardiovasc Drug Rev, 1999, 17: 199-224.
-
5[5]The EPILOG investigators. Platelet glycoprotein Ⅱ b/Ⅲ a receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med, 1997, 336:1689-1696.
-
6[6]EPIC investigators. Use of a monoclonal antibady directed against the platelet glycoprotein Ⅱ b/Ⅲ a receptor in high-risk coronary angioplasty. N Engl J Med, 1994, 330:956-961.
-
7[7]The IMPACT- Ⅱ investigators. Randomised placebo-controlled trial of eptifibation on complications of percutaneous coronary intervention:IMPACT- Ⅱ . Lancet, 1997, 49: 1422-1428.
-
8[8]The RESTORE investigators. Effects of platelet glycoprotein Ⅱ b/Ⅲ a blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Circulation, 1997,96: 1445-1453.
-
9[9]The ERASER investigators. Acute platelet inhibition with abciximab does not reduce in-stent restenosis. The ERASER Study. Circulation,1999, 100: 799-806.
-
10[10]The CAPTURE investigators. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory angina: the CAPTURE Study Lancet, 1997, 349:1429-1435.
同被引文献26
-
1任霞,王字玲,周虹.血小板膜糖蛋白GPⅡb/Ⅲa的结构及激活机制研究进展[J].中国输血杂志,2005,18(2):159-161. 被引量:6
-
2马建林,王圣,李新明,苏哲坦,李斌,陈关良,林劲,王卫.冠心病患者D-二聚体、血小板膜糖蛋白测定及临床意义[J].中华心血管病杂志,2005,33(8):724-726. 被引量:21
-
3奚晓东,赵益明,吴强,蒋惠源,李佩霞,阮长耿.血小板膜糖蛋白酶联免疫测定法的建立及应用[J].中华医学检验杂志,1996,19(4):233-237. 被引量:13
-
4Wugx,Li FG,Li Px,et al.Detection of plasma alphagranule membrane protein(GMP-140)using radiolabeled monoclonal antibodies in thrombotic disease[J].Haemostasis,1993,23:121-128.
-
5Coller BS.A new murine monoclonal antibody receptors an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein Ⅱ b/m a complex[J].J Clin Inwest,1985,76:101-108.
-
6Byzova TV,RabbaniR,Dsouza S,et al.Role of integrin alpha(v)beta3 in vascular biology[J].Thromb Haemost,1998,80(5):726-734.
-
7Coller BS.Blockade of platelet Ⅱ b/Ⅲ a a receptors as an an-tithrombotic strategy[J].Circulation,1995,92:2373-2380.
-
8White JG,Leistikow EL,Escolar G.Platelet membrane responses to surface and suspension activation[J].Blood Cells,1990,16:43-48.
-
9Andrews RK,Fox jEB.Platelet receptors in hemostas is[J].Curr opin Biol,1990,2:894.
-
10Paolo P,Pier G M.The humans platelet membrane glycoprotein Ⅱ b/Ⅲ a a complex:a multifunctional adhesion receptor[J].haematologiea.1992,77:162-168.
-
1杨威,夏斌赞.血小板膜糖蛋白Ⅱb/Ⅲa拮抗剂─新型的抗血小板药[J].中国动脉硬化杂志,1996,4(3):234-236. 被引量:2
-
2余望生,赵相印.纤溶酶系统在动脉血栓形成中的作用[J].临床内科杂志,1994,11(4):14-15.
-
3柴树人,杨沐.肾病综合征合并动脉血栓形成5例报告[J].安徽医学,1995,16(6):73-74. 被引量:1
-
4黄巨恩,胡世凤,邓桂祥,黄康,李校堃,肖健.碱性成纤维细胞生长因子对兔血液凝固时间的影响[J].中国药理学通报,2007,23(5):699-700. 被引量:5
-
5张颖冬.动脉血栓性疾病的遗传性因素[J].中国卒中杂志,2006,1(11):810-817.
-
6谢协驹,谢富生,莫燕娜,陈世民.降低红细胞压积对家兔颈总动脉血栓形成的影响[J].中国病理生理杂志,1995,11(2):198-198. 被引量:3
-
7李黔宁.血管壁切应力的优与非优[J].医学与哲学,1998,19(11):573-575.
-
8赵宝全,章金刚,李前,付爱玲,贾莉玮,郭艳茹,周建平,孙曼霁.人蛋白C突变体转基因小鼠的建立及乳腺表达[J].中国药理通讯,2005,22(3):42-43.
-
9白秀萍,田立国,李学奇.克栓胶囊对实验动物体内血栓形成的影响及其机制[J].血栓与止血学,2011,17(3):124-126.
-
10胡世凤,黄巨恩,谢露,李校坤,莫书荣,覃小燕,郭维坚.碱性成纤维细胞生长因子对大鼠动脉血栓形成的影响[J].广西医科大学学报,2004,21(5):671-673. 被引量:8